IGFBP-4 and -5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells

Reproductive Biology and Endocrinology

Volumn 12, Issue 1, 2014, Pages

  Crosley, Erin J ^a   Dunk, Caroline E ^b   Beristain, Alexander G ^c,d   Christians, Julian K ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

IGFBP 4; IGFBP 5; Insulin like growth factor binding proteins; PAPP A; PAPP A2; Pappalysins; Trophoblast migration

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; PAPPA2 PROTEIN, HUMAN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN B; SOMATOMEDIN C;

ARTICLE; ASSAY; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; FEMALE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GENE LOCATION; GESTATIONAL AGE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PLACENTA; SYNCYTIOTROPHOBLAST; TROPHOBLAST; BIOSYNTHESIS; CELL LINE; CELL MOTION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; PREGNANCY;

CELL LINE; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; TROPHOBLASTS;

EID: 84924096968     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-12-123     Document Type: Article

References (52)

1. Knofler M: Critical growth factors and signalling pathways controlling human trophoblast invasion. Int J Dev Biol 2010, 54:269-280. 10.1387/ijdb.082769mk
2. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005, 308:1592-1594. 10.1126/science.1111726
3. Nayak NR, Giudice LC: Comparative biology of the IGF system in endometrium, decidua, and placenta, and clinical implications for foetal growth and implantation disorders. Placenta 2003, 24:281-296. 10.1053/plac.2002.0906
4. Sferruzzi-Perri AN, Owens JA, Pringle KG, Roberts CT: The neglected role of insulin-like growth factors in the maternal circulation regulating fetal growth. J Physiol 2011, 589:7-20. 10.1113/jphysiol.2010.198622
5. Murphy LJ: Insulin-like growth factor-binding proteins: functional diversity or redundancy? J Mol Endocrinol 1998, 21:97-107. 10.1677/jme.0.0210097
6. Baxter RC: Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 2000, 278:E967-E976.
7. Bunn RC, Fowlkes JL: Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab 2003, 14:176-181. 10.1016/S1043-2760(03)00049-3
8. Bowman CJ, Streck RD, Chapin RE: Maternal-Placental Insulin-Like Growth Factor (IGF) Signaling and its Importance to Normal Embryo-Fetal Development. Birth Defects Res B Dev Reprod Toxicol 2010, 89:339-349. 10.1002/bdrb.20249
9. Wheatcroft SB, Kearney MT: IGF-dependent and IGF-independent actions of IGF-binding protein-1 and-2: implications for metabolic homeostasis. Trends Endocrinol Metab 2009, 20:153-162. 10.1016/j.tem.2009.01.002
10. Gleeson LM, Chakraborty C, McKinnon T, Lala PK: Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein kinase pathway. J Clin Endocrinol Metab 2001, 86:2484-2493.
11. Forbes K, Souquet B, Garside R, Aplin JD, Westwood M: Transforming Growth Factor-beta (TGF beta) Receptors I/II Differentially Regulate TGF beta 1 and IGF-Binding Protein-3 Mitogenic Effects in the Human Placenta. Endocrinology 2010, 151:1723-1731. 10.1210/en.2009-0896
12. Mazerbourg S, Callebaut I, Zapf J, Mohan S, Overgaard M, Monget P: Update on IGFBP-4: regulation of IGFBP-4 levels and functions, in vitro and in vivo. Growth Hormon IGF Res 2004, 14:71-84. 10.1016/j.ghir.2003.10.002
13. Zadeh SM, Binoux M: The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Endocrinology 1997, 138:3069-3072. 10.1210/endo.138.7.5380
14. Andress DL, Loop SM, Zapf J, Kiefer MC: Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem Biophys Res Commun 1993, 195:25-30. 10.1006/bbrc.1993.2004
15. Giudice LC, Conover CA, Bale L, Faessen GH, Ilg K, Sun I, Imani B, Suen LF, Irwin JC, Christiansen M, Overgaard MT, Oxvig C: Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: Evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J Clin Endocrinol Metab 2002, 87:2359-2366. 10.1210/jcem.87.5.8448
16. Christians JK, Gruslin A: Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction. Prenat Diagn 2010, 30:815-820. 10.1002/pd.2583
17. Overgaard MT, Boldt HB, Laursen LS, Sottrup-Jensen L, Conover CA, Oxvig C: Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. J Biol Chem 2001, 276:21849-21853. 10.1074/jbc.M102191200
18. Macintire K, Tuohey L, Ye L, Palmer K, Gantier M, Tong S, Kaitu'u-Lino TJ: PAPPA2 is increased in severe early onset pre-eclampsia and upregulated with hypoxia. Reprod Fertil Dev 2014, 26:351-357. 10.1071/RD12384
19. Paiva P, Whitehead C, Saglam B, Palmer K, Tong S: Measurement of mRNA Transcripts of Very High Placental Expression in Maternal Blood as Biomarkers of Preeclampsia. J Clin Endocrinol Metab 2011, 96:E1807-E1815. 10.1210/jc.2011-1233
20. Varkonyi T, Nagy B, Fule T, Tarca AL, Karaszi K, Schoenleber J, Hupuczi P, Mihalik N, Kovalszky I, Rigo J, Meiri H, Papp Z, Romero R, Than NG: Microarray Profiling Reveals That Placental Transcriptomes of Early-onset HELLP Syndrome and Preeclampsia Are Similar. Placenta 2011, 32:S21-S29.
21. Whitehead CL, Walker SP, Ye L, Mendis S, Kaitu'u-Lino TJ, Lappas M, Tong S: Placental Specific mRNA in the Maternal Circulation Are Globally Dysregulated in Pregnancies Complicated by Fetal Growth Restriction. J Clin Endocrinol Metab 2013, 98:E429-E436. 10.1210/jc.2012-2468
22. Crosley EJ, Durland U, Seethram K, Macrae S, Gruslin A, Christians JK: First-Trimester Levels of Pregnancy-Associated Plasma Protein A2 (PAPP-A2) in the Maternal Circulation Are Elevated in Pregnancies That Subsequently Develop Preeclampsia. Reprod Sci 2014, 21:754-760. 10.1177/1933719113512532
23. Han VKM, Carter AM: Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 2000, 21:289-305. 10.1053/plac.1999.0498
24. Graham CH, Hawley TS, Hawley RG, Macdougall JR, Kerbel RS, Khoo N, Lala PK: Establishment and Characterization of 1st Trimester Human Trophoblast Cells with Extended Life-Span. Exp Cell Res 1993, 206:204-211. 10.1006/excr.1993.1139
25. Hannan NJ, Paiva P, Dimitriadis E, Salamonsen LA: Models for study of human embryo implantation: choice of cell lines? Biol Reprod 2010, 82:235-245. 10.1095/biolreprod.109.077800
26. Lee BPL, Rushlow WJ, Chakraborty C, Lala PK: Differential gene expression in premalignant human trophoblast: Role of IGFBP-5. Int J Cancer 2001, 94:674-684. 10.1002/ijc.1532
27. Tsuboi R, Shi CM, Sato C, Cox GN, Ogawa H: Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models. J Investig Dermatol 1995, 104:199-203. 10.1111/1523-1747.ep12612755
28. Yu J, Iwashita M, Kudo Y, Takeda Y: Phosphorylated insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) inhibits while non-phosphorylated IGFBP-1 stimulates IGF-I-induced amino acid uptake by cultured trophoblast cells. Growth Hormon IGF Res 1998, 8:65-70. 10.1016/S1096-6374(98)80323-7
29. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ: Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 1995, 270:20424-20431. 10.1074/jbc.270.35.20424
30. Lacey H, Haigh T, Westwood M, Aplin JD: Mesenchymally-derived insulin-like growth factor 1 provides a paracrine stimulus for trophoblast migration. BMC Dev Biol 2002, 2:5. 10.1186/1471-213X-2-5
31. Aplin JD, Lacey H, Haigh T, Jones CJ, Chen CP, Westwood M: Growth factor-extracellular matrix synergy in the control of trophoblast invasion. Biochem Soc Trans 2000, 28:199-202.
32. Kabir-Salmani M, Shiokawa S, Akimoto Y, Sakai K, Iwashita M: The role of alpha(5)beta(1)-integrin in the IGF-I-induced migration of extravillous trophoblast cells during the process of implantation. Mol Hum Reprod 2004, 10:91-97. 10.1093/molehr/gah014
33. Irving JA, Lala PK: Functional-Role of Cell-Surface Integrins on Human Trophoblast Cell-Migration - Regulation by Tgf-Beta, Igf-Ii, and Igfbp-1. Exp Cell Res 1995, 217:419-427. 10.1006/excr.1995.1105
34. Hamilton GS, Lysiak JJ, Han VKM, Lala PK: Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res 1998, 244:147-156. 10.1006/excr.1998.4195
35. Qiu Q, Basak A, Mbikay M, Tsang BK, Gruslin A: Role of pro-IGF-II processing by proprotein convertase 4 in human placental development. Proc Natl Acad Sci U S A 2005, 102:11047-11052. 10.1073/pnas.0502357102
36. McKinnon T, Chakraborty C, Gleeson LM, Chidiac P, Lala PK: Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab 2001, 86:3665-3674. 10.1210/jcem.86.8.7711
37. Stewart CE, Rotwein P: Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 1996, 76:1005-1026.
38. Ueno K, Hirata H, Majid S, Tabatabai ZL, Hinoda Y, Dahiya R: IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma. Int J Cancer 2011, 129:2360-2369. 10.1002/ijc.25899
39. Culouscou JM, Shoyab M: Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein. Cancer Res 1991, 51:2813-2819.
40. Damon SE, Maddison L, Ware JL, Plymate SR: Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation. Endocrinology 1998, 139:3456-3464.
41. Diehl D, Hoeflich A, Wolf E, Lahm H: Insulin-like growth factor (IGF)-binding protein-4 inhibits colony formation of colorectal cancer cells by IGF-independent mechanisms. Cancer Res 2004, 64:1600-1603. 10.1158/0008-5472.CAN-03-2844
42. Huang J, Tabata S, Kakiuchi S, Van The T, Goto H, Hanibuchi M, Nishioka Y: Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target. Oncotarget 2013, 4:1172-1184.
43. Beattie J, Allan GJ, Lochrie JD, Flint DJ: Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem J 2006, 395:1-19. 10.1042/BJ20060086
44. Qiu Q, Bell M, Lu X, Yan X, Rodger M, Walker M, Wen S, Bainbridge S, Wang H, Gruslin A: Significance of IGFBP-4 in the Development of Fetal Growth Restriction. J Clin Endocrinol Metab 2012, 97:E1429-E1439. 10.1210/jc.2011-2511
45. Jones JI, Gockerman A, Busby WH Jr, Camacho-Hubner C, Clemmons DR: Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 1993, 121:679-687. 10.1083/jcb.121.3.679
46. Han VKM, Bassett N, Walton J, Challis JRG: The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: Evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab 1996, 81:2680-2693.
47. Hu YX, Tan RS, MacCalman CD, Eastabrook G, Park SH, Dutz JP, von Dadelszen P: IFN-gamma-mediated extravillous trophoblast outgrowth inhibition in first trimester explant culture: a role for insulin-like growth factors. Mol Hum Reprod 2008, 14:281-289. 10.1093/molehr/gan018
48. Street ME, Seghini P, Fieni S, Ziveri MA, Volta C, Martorana D, Viani I, Gramellini D, Bernasconi S: Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol 2006, 155:567-574. 10.1530/eje.1.02251
49. Wang J, Qiu Q, Haider M, Bell M, Gruslin A, Christians JK: Expression of pregnancy-associated plasma protein A2 during pregnancy in human and mouse. J Endocrinol 2009, 202:337-345. 10.1677/JOE-09-0136
50. Nishizawa H, Pryor-Koishi K, Suzuki M, Kato T, Kogo H, Sekiya T, Kurahashi H, Udagawa Y: Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients. Mol Hum Reprod 2008, 14:595-602. 10.1093/molehr/gan054
51. Wagner PK, Christians JK: Altered placental expression of PAPPA2 does not affect birth weight in mice. Reprod Biol Endocrinol 2010, 8:90. 10.1186/1477-7827-8-90
52. Wagner PK, Otomo A, Christians JK: Regulation of pregnancy-associated plasma protein A2 (PAPPA2) in a human placental trophoblast cell line (BeWo). Reprod Biol Endocrinol 2011, 9:48. 10.1186/1477-7827-9-48